The first trial of an experimental treatment for liver cancer, using X-ray imageable microscopic beads loaded with a targeted anti-cancer drug placed directly in the liver, has begun.
The National Institute for Health Research Clinical Research Network Oral and Dental Health Specialty has announced a new opportunity to identify future priorities relating to oral and dental health research.
UCL Business and AGA Nanotech Ltd have concluded a licensing agreement for use of TIPS microparticle technology in directing the controlled delivery of antimicrobial agents in the healthcare setting.
UCL spinout company Autolus has secured £59 million of investment to develop T-cell therapies that could revolutionise the way cancer is treated.
An investigational treatment that mimics a key clotting enzyme is effective, safe, and may one day eliminate the need for blood products for people with a life-threatening blood disease, according to a study published today.
The BRC spoke with Dr Jonathan Schott, consultant neurologist and dementia researcher from the UCL Institute of Neurology about detection, trends and the future for Alzheimer’s disease during World Alzheimer’s Month.